California Mother Claims Zofran Caused Child’s Heart Birth Defect

April 06, 2015 – – A mother from Oakland, California, is one of the latest to file a lawsuit against pharmaceutical giant GlaxoSmithKline (GSK). This lawsuit is in relation to child birth defects in the plaintiff’s son, J.S., which she believes to have been caused by Zofran (ondansetron). This is the third in a set of lawsuits filed against GSK for the alleged side effects of its drug, which is used to prevent vomiting and nausea during pregnancy. To read summaries of other lawsuits, visit: zofranlegal.com.

“We are currently speaking with several parents from across the United States about potential lawsuits for child birth defects,” explains Michael Monheit, Esq., of Monheit Law. “This is a subject close to my heart, as I have a child who has experienced developmental delays.”

Other similar lawsuits against GSK claim that Zofran has been responsible for eleven different birth defects. In this filing, the plaintiff was prescribed Zofran for extreme morning sickness during the first trimester of her pregnancy. At birth, her son was diagnosed with supraventricular tachycardia (SVT) and she claims that this was caused by the drug. There is no family history of SVT and the plaintiff was not aware that Zofran could potentially cause birth defects. In the complaint she states that had she known that Zofran could cause birth defects, she would not have taken it.

J.S. is suffering from various health problems due to SVT, which includes rapid breathing, shortness of breath and shallow breathing. As a result, he has to take regular medications. Indeed, he is on a permanent prescription for Digoxin.

In her complaint, the plaintiff is requesting compensation for the various medical expenses her family has incurred. Additionally, she is claiming against GSK for the pain and suffering that J.S. has endured and will continue to endure as a result of his birth defect. Finally, she is seeking compensation for the severe emotional distress that she is suffering herself.

SVT is a medical condition in which the heart beats at an above normal rate. Usually, sufferers have a heartbeat of at least 100 beats per minute, which is much more rapid than the average of 60 to 90 beats per minute. The condition stops the muscles of the heart from relaxing between each beat. As a result, the chambers do not fill properly and are hence incapable of properly supplying the body with oxygenated blood. It is one of the most common types of heart arrhythmia in children.

Each case is different, as each child is unique and individual. As such, it is not possible to predict the outcome of a particular case or the level of compensation that will be awarded. But for those who are interested in learning more about these cases, you can click here. Those who do so will find out about other cases currently filed against the pharmaceutical giant in relation to Zofran and its alleged connection to various birth defects.

CONTACT DETAILS:
ZofranLegal.com
Michael Monheit – 1-877-620-8411 – michael@monheit.com
1368 Barrowdale Road
Rydal, PA 19046

ReleaseID: 60000592